ArTS Archivio della ricerca di Trieste

STOCCO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.967
EU - Europa 9.228
AS - Asia 7.353
SA - Sud America 1.039
Continente sconosciuto - Info sul continente non disponibili 696
AF - Africa 285
OC - Oceania 36
Totale 32.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.669
PL - Polonia 2.590
SG - Singapore 2.525
IT - Italia 2.245
CN - Cina 1.549
VN - Vietnam 844
BR - Brasile 774
SE - Svezia 760
HK - Hong Kong 671
DE - Germania 659
BD - Bangladesh 502
FI - Finlandia 451
FR - Francia 435
UA - Ucraina 429
GB - Regno Unito 398
KR - Corea 303
RU - Federazione Russa 292
NL - Olanda 243
IN - India 211
TR - Turchia 198
IE - Irlanda 170
BG - Bulgaria 138
CA - Canada 122
JP - Giappone 113
AR - Argentina 91
MX - Messico 85
MA - Marocco 82
BE - Belgio 63
AT - Austria 61
ES - Italia 58
IQ - Iraq 56
PK - Pakistan 49
ZA - Sudafrica 48
SA - Arabia Saudita 46
SN - Senegal 45
ID - Indonesia 41
EC - Ecuador 37
PH - Filippine 32
CO - Colombia 30
EG - Egitto 30
PT - Portogallo 30
AU - Australia 29
CL - Cile 28
TH - Thailandia 28
VE - Venezuela 27
CH - Svizzera 22
CZ - Repubblica Ceca 21
IR - Iran 21
LT - Lituania 21
PE - Perù 21
UZ - Uzbekistan 21
CR - Costa Rica 20
TN - Tunisia 20
JO - Giordania 19
GR - Grecia 16
JM - Giamaica 16
PY - Paraguay 15
RO - Romania 15
AE - Emirati Arabi Uniti 14
SI - Slovenia 14
TW - Taiwan 14
AZ - Azerbaigian 13
MY - Malesia 13
RS - Serbia 13
DK - Danimarca 12
DZ - Algeria 12
GT - Guatemala 11
IL - Israele 11
NO - Norvegia 11
KE - Kenya 10
AL - Albania 9
KW - Kuwait 9
MD - Moldavia 8
UY - Uruguay 8
BO - Bolivia 7
HN - Honduras 7
HR - Croazia 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
BA - Bosnia-Erzegovina 6
ET - Etiopia 6
HU - Ungheria 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
EE - Estonia 5
GE - Georgia 5
MN - Mongolia 5
PA - Panama 5
SV - El Salvador 5
CI - Costa d'Avorio 4
KG - Kirghizistan 4
LB - Libano 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
Totale 31.851
Salva come PNG Salva come JPEG
Città #
Warsaw 2.411
Ashburn 1.617
Singapore 1.460
Woodbridge 1.052
Fairfield 1.014
Ann Arbor 924
Chandler 800
San Jose 780
Trieste 665
Houston 645
Hong Kong 636
Wilmington 500
Seattle 449
Council Bluffs 409
Jacksonville 388
Beijing 348
Cambridge 345
Munich 294
Seoul 280
Ho Chi Minh City 277
Hefei 258
Helsinki 242
Princeton 236
Los Angeles 231
Boardman 230
Hanoi 199
Chicago 188
Columbus 187
Milan 176
Santa Clara 166
Dallas 157
Dublin 152
Lauterbourg 150
New York 147
Moscow 138
Izmir 136
Sofia 136
Zgierz 133
London 122
Rome 116
Frankfurt am Main 96
Buffalo 95
The Dalles 95
Dearborn 91
São Paulo 83
Phoenix 67
Tokyo 66
Casablanca 65
Düsseldorf 55
Orem 55
San Diego 54
Brussels 51
Shanghai 50
Dakar 45
Atlanta 44
Lappeenranta 43
Dong Ket 42
Redondo Beach 41
Memphis 39
Vienna 38
Nuremberg 37
Redwood City 36
Turku 36
Montreal 35
Chennai 34
Denver 34
Falls Church 33
Manchester 33
Mumbai 33
Toronto 31
Amsterdam 30
Da Nang 30
Guangzhou 30
Brooklyn 29
Johannesburg 28
Washington 28
Bologna 27
Nanjing 27
Stockholm 27
Boston 26
Des Moines 26
Haiphong 26
Naples 26
Curitiba 24
Charlotte 23
Jinan 23
Turin 23
Bremen 22
Belo Horizonte 21
Genoa 21
Hangzhou 21
Istanbul 21
Rio de Janeiro 21
Wroclaw 21
Tianjin 20
Venice 20
Verona 20
Baghdad 19
Mexico City 19
Pune 19
Totale 21.069
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 549
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 543
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 517
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 491
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 465
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 456
Pharmacogenetics of thiopurines 454
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 438
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 436
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 423
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 423
Type i interferon-mediated autoinflammation due to DNase II deficiency 419
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 412
Pharmacogenetics of treatments for inflammatory bowel disease 383
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 353
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 343
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 343
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 318
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 313
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 304
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 303
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 302
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 294
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 294
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 292
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 278
ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. 277
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 274
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells 272
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 272
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 272
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 272
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 271
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 270
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 267
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 266
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 261
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 259
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 259
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 259
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 255
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 251
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 250
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 247
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 244
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 243
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 242
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 240
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 238
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 236
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 235
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 232
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 231
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 231
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 228
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 227
SERS of cells: What can we learn from cell lysates? 227
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 224
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 217
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 213
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 210
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 207
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 207
Personalized therapies in pediatric inflammatory and autoimmune diseases. 205
Letter: TPMT activity and age in IBD patients. 202
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 200
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 198
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 197
Cancer Pharmacogenomics 196
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 194
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 193
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy 192
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 192
Inflammatory Bowel Disease 191
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 191
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 190
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 184
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 182
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 182
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 181
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 178
Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia. 177
TPMT genotype and the use of thiopurines in pediatric inflammatory bowel disease. 176
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 175
Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells 175
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 175
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. 174
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 173
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 173
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 173
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 172
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 171
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile 169
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 167
Glucocorticoid receptor polymorphisms in inflammatory bowel disease. 166
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress 166
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia 165
A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis 164
Induced pluripotent stem cells as a model for therapy personalizationof pediatric patients: Disease modeling and drug adverse effects prevention 164
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 164
Totale 25.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.371 0 0 90 140 40 141 122 55 180 161 95 347
2022/20232.390 237 370 161 347 223 373 22 204 264 49 89 51
2023/20241.698 76 99 64 101 176 144 298 331 30 53 205 121
2024/20254.788 96 257 353 417 390 539 330 341 645 579 379 462
2025/202610.617 995 520 689 872 891 858 1.427 370 1.190 1.370 869 566
2026/20271.328 447 550 331 0 0 0 0 0 0 0 0 0
Totale 32.604